tiprankstipranks
Promising Potential of Palvella Therapeutics’ QTORIN Platform Drives Buy Rating
PremiumRatingsPromising Potential of Palvella Therapeutics’ QTORIN Platform Drives Buy Rating
17d ago
Four new option listings and one option delisting on January 29th
Premium
The Fly
Four new option listings and one option delisting on January 29th
24d ago
Palvella Therapeutics announces results from Phase 2 study of QTORIN
Premium
The Fly
Palvella Therapeutics announces results from Phase 2 study of QTORIN
1M ago
Twelve option delistings on December 23rd
PremiumThe FlyTwelve option delistings on December 23rd
2M ago
Palvella Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Palvella Therapeutics initiated with an Overweight at Cantor Fitzgerald
2M ago
Palvella Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Palvella Therapeutics initiated with an Overweight at Cantor Fitzgerald
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100